[
  {
    "text": "<p>New funding applications are referred to one of Pharmac's Funding Application Advisors (FAAs), who'll review the application to ensure they have the relevant information to undertake a preliminary analysis.&nbsp; They may seek more information if required.</p>\r\n<p><a class=\"external-link\" href=\"https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/new-funding-applications/\" rel=\"nofollow\">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/new-funding-applications/</a></p>",
    "position": 0,
    "name": "Application Received",
    "last": false,
    "events": [
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Jan 2011",
          "fs": "Jan 2011",
          "change": null
        },
        "Event_Description": {
          "s": "Application received",
          "fs": "Application received",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000170Z72AI"
          },
          "Id": "a0POZ00000170Z72AI",
          "Event_Date__c": "2011-01-01",
          "Event_Description__c": "Application received",
          "Stage__c": "Application Received",
          "Formatted_Date__c": "Jan 2011",
          "Status_History__c": "a132P000000AphsQAC"
        },
        "change": null
      }
    ],
    "dateString": "Jan 2011",
    "collapsed": false,
    "checked": true
  },
  {
    "text": "<p>Pharmac is identifying and gathering information required to get clinical advice.  The <a class=\"external-link\" href=\"https://pharmac.govt.nz/about/expert-advice/pharmacology-and-therapeutics-advisory-committee-ptac/\" rel=\"nofollow\">Pharmacology and Therapeutics Advisory Committee (PTAC)</a>  meets quarterly. There are also around 20 expert <a class=\"external-link\" href=\"https://pharmac.govt.nz/about/expert-advice/specialist-advisory-committees/\" rel=\"nofollow\">Specialist Advisory Committees (SACs)</a>, previously expert Subcommittees, which provide clinical evaluations in specialist areas. Specialist Advisory Committees meet as required to discuss issues referred to them by PTAC or Pharmac.</p>\n<p style=\"height: 20px\">&nbsp;</p>\n<p>In November 2021, we introduced separate terms of reference for the SACs to make clear that these committees have different, but complementary, roles, expertise and perspectives to PTAC.</p>\n<p style=\"height: 15px\">&nbsp;</p>\n<p>PTAC and SACs may make recommendations to Pharmac that differ from each other when looking at the same evidence. Pharmac considers the recommendations provided by all our clinical advisory committees when assessing applications.</p>\n<p style=\"height: 20px\">&nbsp;</p>\n<p><a class=\"external-link\" href=\"https://pharmac.govt.nz/about/expert-advice/pharmacology-and-therapeutics-advisory-committee-ptac/ptac-terms-of-reference-july-2021/\" rel=\"nofollow\">PTAC</a>  and <a class=\"external-link\" href=\"https://pharmac.govt.nz/about/expert-advice/specialist-advisory-committees/specialist-advisory-committee-terms-of-reference//\" rel=\"nofollow\">Specialist Advisory Committees</a> records of the meeting will be published on this website in accordance with the Terms of Reference.</p>",
    "position": 1,
    "name": "Seeking Clinical Advice",
    "last": false,
    "events": [
      {
        "Summary": {
          "s": "Recommended listing inf glucose 4% with sodium chloride 0.18%, in both 500 and 1,000 ml forms, on the Hospital Medicines List.",
          "fs": "Recommended listing inf glucose 4% with sodium chloride 0.18%, in both 500 and 1,000 ml forms, on the Hospital Medicines List.",
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": "Recommended for funding with no priority",
          "fs": "Recommended for funding with no priority",
          "change": null
        },
        "Links": {
          "s": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-blood-and-blood-forming-organs-group-minutes-2013-02.pdf \" target=\"_blank\">Hospital Pharmaceuticals Subcommittee minutes</a>",
          "fs": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-blood-and-blood-forming-organs-group-minutes-2013-02.pdf \" target=\"_blank\">Hospital Pharmaceuticals Subcommittee minutes</a>",
          "change": null
        },
        "Formatted_Date": {
          "s": "Dec 2011",
          "fs": "Dec 2011",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice received from Hospital Pharmaceuticals Subcommittee at meeting Tuesday 6 December 2011.",
          "fs": "Clinical advice received from Hospital Pharmaceuticals Subcommittee at meeting Tuesday 6 December 2011.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000170Z82AI"
          },
          "Id": "a0POZ00000170Z82AI",
          "Event_Date__c": "2011-12-06",
          "Event_Description__c": "Clinical advice received from Hospital Pharmaceuticals Subcommittee at meeting Tuesday 6 December 2011.",
          "Stage__c": "Seeking Clinical Advice",
          "Links__c": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-blood-and-blood-forming-organs-group-minutes-2013-02.pdf \" target=\"_blank\">Hospital Pharmaceuticals Subcommittee minutes</a>",
          "Outcome__c": "Recommended for funding with no priority",
          "Summary__c": "Recommended listing inf glucose 4% with sodium chloride 0.18%, in both 500 and 1,000 ml forms, on the Hospital Medicines List.",
          "Formatted_Date__c": "Dec 2011",
          "Status_History__c": "a132P000000ApwiQAC"
        },
        "change": null
      },
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": "Not recommended for inclusion (HML)",
          "fs": "Not recommended for inclusion (HML)",
          "change": null
        },
        "Links": {
          "s": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-blood-and-blood-forming-organs-group-minutes-2013-02.pdf \" target=\"_blank\">PTAC minutes</a>",
          "fs": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-blood-and-blood-forming-organs-group-minutes-2013-02.pdf \" target=\"_blank\">PTAC minutes</a>",
          "change": null
        },
        "Formatted_Date": {
          "s": "Feb 2013",
          "fs": "Feb 2013",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 14 February 2013.",
          "fs": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 14 February 2013.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000170Z92AI"
          },
          "Id": "a0POZ00000170Z92AI",
          "Event_Date__c": "2013-02-14",
          "Event_Description__c": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 14 February 2013.",
          "Stage__c": "Seeking Clinical Advice",
          "Links__c": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-blood-and-blood-forming-organs-group-minutes-2013-02.pdf \" target=\"_blank\">PTAC minutes</a>",
          "Outcome__c": "Not recommended for inclusion (HML)",
          "Formatted_Date__c": "Feb 2013",
          "Status_History__c": "a132P000000AqIjQAK"
        },
        "change": null
      },
      {
        "Summary": {
          "s": "Following a clinician application for glucose 4% with sodium chloride 0.18% (Bart&#39;s solution), the Subcommittee recommended that it not be listed on the HML, given the risk of seizures in children and the availability of a 5% with NaCl 0.2% solutiion. The Subcommittee noted that it would be willing to review this recommendation following the provision of clinical evidence to support a clinical benefit with the use of Bart&#39;s solution over alternative available treatment options.",
          "fs": "Following a clinician application for glucose 4% with sodium chloride 0.18% (Bart&#39;s solution), the Subcommittee recommended that it not be listed on the HML, given the risk of seizures in children and the availability of a 5% with NaCl 0.2% solutiion. The Subcommittee noted that it would be willing to review this recommendation following the provision of clinical evidence to support a clinical benefit with the use of Bart&#39;s solution over alternative available treatment options.",
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": "These minutes have been ratified by the Pharmacology and Therapeutic Advisory Committee.",
          "fs": "These minutes have been ratified by the Pharmacology and Therapeutic Advisory Committee.",
          "change": null
        },
        "Outcome": {
          "s": "Decline",
          "fs": "Decline",
          "change": null
        },
        "Links": {
          "s": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-analgesic-subcommittee-minutes-2013-09.pdf\" target=\"_blank\">Analgesic Subcommittee minutes</a>",
          "fs": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-analgesic-subcommittee-minutes-2013-09.pdf\" target=\"_blank\">Analgesic Subcommittee minutes</a>",
          "change": null
        },
        "Formatted_Date": {
          "s": "Sep 2013",
          "fs": "Sep 2013",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice received from Analgesic Subcommittee at meeting Tuesday 24 September 2013.",
          "fs": "Clinical advice received from Analgesic Subcommittee at meeting Tuesday 24 September 2013.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000170ZD2AY"
          },
          "Id": "a0POZ00000170ZD2AY",
          "Event_Date__c": "2013-09-24",
          "Event_Description__c": "Clinical advice received from Analgesic Subcommittee at meeting Tuesday 24 September 2013.",
          "Stage__c": "Seeking Clinical Advice",
          "Links__c": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-analgesic-subcommittee-minutes-2013-09.pdf\" target=\"_blank\">Analgesic Subcommittee minutes</a>",
          "Outcome__c": "Decline",
          "Summary__c": "Following a clinician application for glucose 4% with sodium chloride 0.18% (Bart&#39;s solution), the Subcommittee recommended that it not be listed on the HML, given the risk of seizures in children and the availability of a 5% with NaCl 0.2% solutiion. The Subcommittee noted that it would be willing to review this recommendation following the provision of clinical evidence to support a clinical benefit with the use of Bart&#39;s solution over alternative available treatment options.",
          "Formatted_Date__c": "Sep 2013",
          "PTAC_Comments__c": "These minutes have been ratified by the Pharmacology and Therapeutic Advisory Committee.",
          "Status_History__c": "a132P000000AqTfQAK"
        },
        "change": null
      },
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": "Decline",
          "fs": "Decline",
          "change": null
        },
        "Links": {
          "s": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-minutes-2014-02.pdf\" target=\"_blank\">PTAC minutes</a>",
          "fs": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-minutes-2014-02.pdf\" target=\"_blank\">PTAC minutes</a>",
          "change": null
        },
        "Formatted_Date": {
          "s": "Feb 2014",
          "fs": "Feb 2014",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 13 February 2014.",
          "fs": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 13 February 2014.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000170ZF2AY"
          },
          "Id": "a0POZ00000170ZF2AY",
          "Event_Date__c": "2014-02-13",
          "Event_Description__c": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 13 February 2014.",
          "Stage__c": "Seeking Clinical Advice",
          "Links__c": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-minutes-2014-02.pdf\" target=\"_blank\">PTAC minutes</a>",
          "Outcome__c": "Decline",
          "Formatted_Date__c": "Feb 2014",
          "Status_History__c": "a132P000000AqbTQAS"
        },
        "change": null
      },
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Aug 2014",
          "fs": "Aug 2014",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice required",
          "fs": "Clinical advice required",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000170ZI2AY"
          },
          "Id": "a0POZ00000170ZI2AY",
          "Event_Date__c": "2014-08-14",
          "Event_Description__c": "Clinical advice required",
          "Stage__c": "Seeking Clinical Advice",
          "Formatted_Date__c": "Aug 2014",
          "Status_History__c": "a132P000000AqkqQAC"
        },
        "change": null
      },
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": "Decline",
          "fs": "Decline",
          "change": null
        },
        "Links": {
          "s": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-minutes-2014-08.pdf\" target=\"_blank\">PTAC minutes</a>",
          "fs": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-minutes-2014-08.pdf\" target=\"_blank\">PTAC minutes</a>",
          "change": null
        },
        "Formatted_Date": {
          "s": "Aug 2014",
          "fs": "Aug 2014",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 14 August 2014.",
          "fs": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 14 August 2014.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000170ZJ2AY"
          },
          "Id": "a0POZ00000170ZJ2AY",
          "Event_Date__c": "2014-08-14",
          "Event_Description__c": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 14 August 2014.",
          "Stage__c": "Seeking Clinical Advice",
          "Links__c": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-minutes-2014-08.pdf\" target=\"_blank\">PTAC minutes</a>",
          "Outcome__c": "Decline",
          "Formatted_Date__c": "Aug 2014",
          "Status_History__c": "a132P000000AqkvQAC"
        },
        "change": null
      },
      {
        "Summary": {
          "s": "Discussed during Matters Arising. Reiterated previous recommendation.",
          "fs": "Discussed during Matters Arising. Reiterated previous recommendation.",
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": "Decline",
          "fs": "Decline",
          "change": null
        },
        "Links": {
          "s": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-minutes-2014-11.pdf\" target=\"_blank\">PTAC minutes</a>",
          "fs": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-minutes-2014-11.pdf\" target=\"_blank\">PTAC minutes</a>",
          "change": null
        },
        "Formatted_Date": {
          "s": "Nov 2014",
          "fs": "Nov 2014",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 6 November 2014.",
          "fs": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 6 November 2014.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000170ZM2AY"
          },
          "Id": "a0POZ00000170ZM2AY",
          "Event_Date__c": "2014-11-06",
          "Event_Description__c": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 6 November 2014.",
          "Stage__c": "Seeking Clinical Advice",
          "Links__c": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-minutes-2014-11.pdf\" target=\"_blank\">PTAC minutes</a>",
          "Outcome__c": "Decline",
          "Summary__c": "Discussed during Matters Arising. Reiterated previous recommendation.",
          "Formatted_Date__c": "Nov 2014",
          "Status_History__c": "a132P000000AqpEQAS"
        },
        "change": null
      },
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Feb 2015",
          "fs": "Feb 2015",
          "change": null
        },
        "Event_Description": {
          "s": "Received Additional Information",
          "fs": "Received Additional Information",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000170ZN2AY"
          },
          "Id": "a0POZ00000170ZN2AY",
          "Event_Date__c": "2015-02-16",
          "Event_Description__c": "Received Additional Information",
          "Stage__c": "Seeking Clinical Advice",
          "Formatted_Date__c": "Feb 2015",
          "Status_History__c": "a132P000000AqsKQAS"
        },
        "change": null
      },
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Apr 2015",
          "fs": "Apr 2015",
          "change": null
        },
        "Event_Description": {
          "s": "Received Additional Information",
          "fs": "Received Additional Information",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000170ZO2AY"
          },
          "Id": "a0POZ00000170ZO2AY",
          "Event_Date__c": "2015-04-01",
          "Event_Description__c": "Received Additional Information",
          "Stage__c": "Seeking Clinical Advice",
          "Formatted_Date__c": "Apr 2015",
          "Status_History__c": "a132P000000Aqu9QAC"
        },
        "change": null
      },
      {
        "Summary": {
          "s": "PTAC recommended that the 1000 ml presentation of glucose 4% with sodium chloride 0.18% (&#39;Bart&#39;s solution) be listed in hospitals (Part II of Section H). PTAC recommended against listing the 500 ml form.    PTAC also recommended referring safety concerns to the Medicines Adverse Reactions Committee of Medsafe, to liase with Medsafe, DHB hospitals and the supplier to introduce safety measures.",
          "fs": "PTAC recommended that the 1000 ml presentation of glucose 4% with sodium chloride 0.18% (&#39;Bart&#39;s solution) be listed in hospitals (Part II of Section H). PTAC recommended against listing the 500 ml form.    PTAC also recommended referring safety concerns to the Medicines Adverse Reactions Committee of Medsafe, to liase with Medsafe, DHB hospitals and the supplier to introduce safety measures.",
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": "Recommended for funding with no priority",
          "fs": "Recommended for funding with no priority",
          "change": null
        },
        "Links": {
          "s": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-minutes-2015-05-updated.pdf\" target=\"_blank\">PTAC minutes</a>",
          "fs": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-minutes-2015-05-updated.pdf\" target=\"_blank\">PTAC minutes</a>",
          "change": null
        },
        "Formatted_Date": {
          "s": "May 2015",
          "fs": "May 2015",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 7 May 2015.",
          "fs": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 7 May 2015.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000170ZP2AY"
          },
          "Id": "a0POZ00000170ZP2AY",
          "Event_Date__c": "2015-05-07",
          "Event_Description__c": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 7 May 2015.",
          "Stage__c": "Seeking Clinical Advice",
          "Links__c": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-minutes-2015-05-updated.pdf\" target=\"_blank\">PTAC minutes</a>",
          "Outcome__c": "Recommended for funding with no priority",
          "Summary__c": "PTAC recommended that the 1000 ml presentation of glucose 4% with sodium chloride 0.18% (&#39;Bart&#39;s solution) be listed in hospitals (Part II of Section H). PTAC recommended against listing the 500 ml form.    PTAC also recommended referring safety concerns to the Medicines Adverse Reactions Committee of Medsafe, to liase with Medsafe, DHB hospitals and the supplier to introduce safety measures.",
          "Formatted_Date__c": "May 2015",
          "Status_History__c": "a132P000000AqvRQAS"
        },
        "change": null
      },
      {
        "Summary": {
          "s": "Discussed in Matters Arising. Reiterated the recommendation to list the 1000 ml presentation in Section H, with a restriction limiting to adults, and a note on the item advising of the evidence of risk.",
          "fs": "Discussed in Matters Arising. Reiterated the recommendation to list the 1000 ml presentation in Section H, with a restriction limiting to adults, and a note on the item advising of the evidence of risk.",
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": "Recommended for funding with no priority",
          "fs": "Recommended for funding with no priority",
          "change": null
        },
        "Links": {
          "s": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-minutes-2015-08.pdf\" target=\"_blank\">PTAC minutes</a>",
          "fs": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-minutes-2015-08.pdf\" target=\"_blank\">PTAC minutes</a>",
          "change": null
        },
        "Formatted_Date": {
          "s": "Aug 2015",
          "fs": "Aug 2015",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 13 August 2015.",
          "fs": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 13 August 2015.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000170ZR2AY"
          },
          "Id": "a0POZ00000170ZR2AY",
          "Event_Date__c": "2015-08-13",
          "Event_Description__c": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 13 August 2015.",
          "Stage__c": "Seeking Clinical Advice",
          "Links__c": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-minutes-2015-08.pdf\" target=\"_blank\">PTAC minutes</a>",
          "Outcome__c": "Recommended for funding with no priority",
          "Summary__c": "Discussed in Matters Arising. Reiterated the recommendation to list the 1000 ml presentation in Section H, with a restriction limiting to adults, and a note on the item advising of the evidence of risk.",
          "Formatted_Date__c": "Aug 2015",
          "Status_History__c": "a132P000000AqyWQAS"
        },
        "change": null
      }
    ],
    "dateString": "Dec 2011",
    "collapsed": false,
    "checked": true
  },
  {
    "text": "<p>Following Clinical Advice, Pharmac staff considers the advice and the funding application under goes an assessment using our&nbsp;<a class=\"external-link\" href=\"https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/factors-for-consideration/\" rel=\"nofollow\">Factors for Consideration</a>&nbsp;framework and seeks additional information as required.</p>\r\n<p>&nbsp;</p>\r\n<p>Research and Economic analysis are undertaken.&nbsp; This focuses on the costs and benefits of a proposed course of action. Economics is based on three fundamental concepts that summarise the issues Pharmac faces daily:&nbsp;</p>\r\n<ul>\r\n<li>Scarcity &ndash; resources will always be insufficient to support all possible activities.</li>\r\n<li>Choices &ndash; due to scarce resources, decisions must be made about how best to use them.</li>\r\n<li>Opportunity cost &ndash; by choosing to use resources one way, we forgo other opportunities to use the same resources.</li>\r\n</ul>\r\n<p>&nbsp;</p>\r\n<p>For further information on the purpose of, and techniques for, undertaking economic analysis in health care, please refer&nbsp;<a class=\"external-link\" href=\"https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/economic-analysis/\" rel=\"nofollow\">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/economic-analysis/</a></p>",
    "position": 2,
    "name": "Under Assessment",
    "last": false,
    "events": [
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Sep 2013",
          "fs": "Sep 2013",
          "change": null
        },
        "Event_Description": {
          "s": "Working to compare options",
          "fs": "Working to compare options",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000170ZE2AY"
          },
          "Id": "a0POZ00000170ZE2AY",
          "Event_Date__c": "2013-09-30",
          "Event_Description__c": "Working to compare options",
          "Stage__c": "Under Assessment",
          "Formatted_Date__c": "Sep 2013",
          "Status_History__c": "a132P000000AqTiQAK"
        },
        "change": null
      },
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Aug 2014",
          "fs": "Aug 2014",
          "change": null
        },
        "Event_Description": {
          "s": "Working to compare options",
          "fs": "Working to compare options",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000170ZK2AY"
          },
          "Id": "a0POZ00000170ZK2AY",
          "Event_Date__c": "2014-08-14",
          "Event_Description__c": "Working to compare options",
          "Stage__c": "Under Assessment",
          "Formatted_Date__c": "Aug 2014",
          "Status_History__c": "a132P000000Aql3QAC"
        },
        "change": null
      },
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "May 2015",
          "fs": "May 2015",
          "change": null
        },
        "Event_Description": {
          "s": "Working to compare options",
          "fs": "Working to compare options",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000170ZQ2AY"
          },
          "Id": "a0POZ00000170ZQ2AY",
          "Event_Date__c": "2015-05-08",
          "Event_Description__c": "Working to compare options",
          "Stage__c": "Under Assessment",
          "Formatted_Date__c": "May 2015",
          "Status_History__c": "a132P000000AqvlQAC"
        },
        "change": null
      }
    ],
    "dateString": "Sep 2013",
    "collapsed": false,
    "checked": true
  },
  {
    "text": "<p>Pharmac staff uses a prioritisation process to compare and rank funding options. Possible opportunities for new investment will always exceed the budget Pharmac has available; therefore, prioritisation is an intrinsic part of Pharmac\u2019s decision-making process.</p>\r\n<p>The relative ranking of options aims to support Pharmac&rsquo;s statutory objective &ldquo;to secure for eligible people in need of pharmaceuticals, the best health outcomes that are reasonably achievable from pharmaceutical treatment and from within the amount of funding provided&rdquo;.</p>\r\n<p>A funding application or proposal is considered ready for prioritisation when sufficient information is available to permit it to be reviewed against Pharmac's Factors for Consideration and to inform a comparison with other possible investment decisions.</p>\r\n<p>There is no guarantee when or if a ranked medicine will be funded.&nbsp;&nbsp;<a class=\"external-link\" href=\"https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/prioritisation/\" rel=\"nofollow\">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/prioritisation/</a></p>",
    "position": 3,
    "name": "Options Compared",
    "last": false,
    "events": [
      {
        "Summary": {
          "s": "This product was not included in the first edition of the HML. This does not preclude further consideration of the product.",
          "fs": "This product was not included in the first edition of the HML. This does not preclude further consideration of the product.",
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Jul 2013",
          "fs": "Jul 2013",
          "change": null
        },
        "Event_Description": {
          "s": "The relative ranking of the pharmaceutical application has been completed.",
          "fs": "The relative ranking of the pharmaceutical application has been completed.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000170ZC2AY"
          },
          "Id": "a0POZ00000170ZC2AY",
          "Event_Date__c": "2013-07-01",
          "Event_Description__c": "The relative ranking of the pharmaceutical application has been completed.",
          "Stage__c": "Options Compared",
          "Summary__c": "This product was not included in the first edition of the HML. This does not preclude further consideration of the product.",
          "Formatted_Date__c": "Jul 2013",
          "Status_History__c": "a132P000000AqQlQAK"
        },
        "change": null
      },
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Aug 2014",
          "fs": "Aug 2014",
          "change": null
        },
        "Event_Description": {
          "s": "The relative ranking of the pharmaceutical application has been completed.",
          "fs": "The relative ranking of the pharmaceutical application has been completed.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000170ZL2AY"
          },
          "Id": "a0POZ00000170ZL2AY",
          "Event_Date__c": "2014-08-29",
          "Event_Description__c": "The relative ranking of the pharmaceutical application has been completed.",
          "Stage__c": "Options Compared",
          "Formatted_Date__c": "Aug 2014",
          "Status_History__c": "a132P000000AqmBQAS"
        },
        "change": null
      }
    ],
    "dateString": "Jul 2013",
    "collapsed": false,
    "checked": true
  },
  {
    "text": "<p>Pharmac is consulting on a proposal to either approve or decline the application.&nbsp;We seek the views of all people who have an interest in our proposals, or who may be affected by them, to obtain feedback on our proposed approaches.</p>\r\n<p><a class=\"external-link\" href=\"https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/having-your-say/\" rel=\"nofollow\">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/having-your-say/</a></p>",
    "position": 4,
    "name": "Under Consultation",
    "last": false,
    "events": [
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Feb 2013",
          "fs": "Feb 2013",
          "change": null
        },
        "Event_Description": {
          "s": "Public consultation for this application is active.",
          "fs": "Public consultation for this application is active.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000170ZA2AY"
          },
          "Id": "a0POZ00000170ZA2AY",
          "Event_Date__c": "2013-02-25",
          "Event_Description__c": "Public consultation for this application is active.",
          "Stage__c": "Under Consultation",
          "Formatted_Date__c": "Feb 2013",
          "Status_History__c": "a132P000000AqKEQA0"
        },
        "change": null
      },
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Apr 2014",
          "fs": "Apr 2014",
          "change": null
        },
        "Event_Description": {
          "s": "Public consultation for this application is active.",
          "fs": "Public consultation for this application is active.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000170ZG2AY"
          },
          "Id": "a0POZ00000170ZG2AY",
          "Event_Date__c": "2014-04-03",
          "Event_Description__c": "Public consultation for this application is active.",
          "Stage__c": "Under Consultation",
          "Formatted_Date__c": "Apr 2014",
          "Status_History__c": "a132P000000AqdnQAC"
        },
        "change": null
      }
    ],
    "dateString": "Feb 2013",
    "collapsed": false,
    "checked": true
  },
  {
    "text": "<p>Following the consultation process, Pharmac staff considers the feedback and identifies any additional information required as part of a gap analysis.&nbsp; The proposal may require further clinical advice, research, and assessment.</p>",
    "position": 5,
    "name": "Reviewing Consultation Feedback",
    "last": false,
    "events": [
      {
        "Summary": {
          "s": "Proposes not to include 4%-glucose forms of the product. Notes that for each of these, it is proposed that other presentations or strengths would be included in the Hospital Medicines List.",
          "fs": "Proposes not to include 4%-glucose forms of the product. Notes that for each of these, it is proposed that other presentations or strengths would be included in the Hospital Medicines List.",
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Mar 2013",
          "fs": "Mar 2013",
          "change": null
        },
        "Event_Description": {
          "s": "Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.",
          "fs": "Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000170ZB2AY"
          },
          "Id": "a0POZ00000170ZB2AY",
          "Event_Date__c": "2013-03-28",
          "Event_Description__c": "Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.",
          "Stage__c": "Reviewing Consultation Feedback",
          "Summary__c": "Proposes not to include 4%-glucose forms of the product. Notes that for each of these, it is proposed that other presentations or strengths would be included in the Hospital Medicines List.",
          "Formatted_Date__c": "Mar 2013",
          "Status_History__c": "a132P000000AqMbQAK"
        },
        "change": null
      },
      {
        "Summary": {
          "s": "This consultation document requests feedback on whether glucose 4% sodium chloride 0.18% solution (Barts solution) should be included on the HML. It requests evidence for a clinical benefit over available treatment options and asks for advice on managing the risks associated with making Barts solution available in hospital areas where children may be treated. This is not a consultation on a listing decision.",
          "fs": "This consultation document requests feedback on whether glucose 4% sodium chloride 0.18% solution (Barts solution) should be included on the HML. It requests evidence for a clinical benefit over available treatment options and asks for advice on managing the risks associated with making Barts solution available in hospital areas where children may be treated. This is not a consultation on a listing decision.",
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": "<a href=\"https://www.pharmac.govt.nz/news/consultation-2014-04-03-barts-solution/\" target=\"_blank\">Consultation letter</a>",
          "fs": "<a href=\"https://www.pharmac.govt.nz/news/consultation-2014-04-03-barts-solution/\" target=\"_blank\">Consultation letter</a>",
          "change": null
        },
        "Formatted_Date": {
          "s": "May 2014",
          "fs": "May 2014",
          "change": null
        },
        "Event_Description": {
          "s": "Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.",
          "fs": "Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000170ZH2AY"
          },
          "Id": "a0POZ00000170ZH2AY",
          "Event_Date__c": "2014-05-02",
          "Event_Description__c": "Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.",
          "Stage__c": "Reviewing Consultation Feedback",
          "Links__c": "<a href=\"https://www.pharmac.govt.nz/news/consultation-2014-04-03-barts-solution/\" target=\"_blank\">Consultation letter</a>",
          "Summary__c": "This consultation document requests feedback on whether glucose 4% sodium chloride 0.18% solution (Barts solution) should be included on the HML. It requests evidence for a clinical benefit over available treatment options and asks for advice on managing the risks associated with making Barts solution available in hospital areas where children may be treated. This is not a consultation on a listing decision.",
          "Formatted_Date__c": "May 2014",
          "Status_History__c": "a132P000000AqetQAC"
        },
        "change": null
      }
    ],
    "dateString": "Mar 2013",
    "collapsed": false,
    "checked": true
  },
  {
    "text": "<p>We refer to our decisions about whether and how particular pharmaceuticals are publicly-funded, as &ldquo;funding decisions&rdquo;.</p>\r\n<p>We consider and assess all funding decisions using the&nbsp;<a class=\"external-link\" href=\"https://www.pharmac.govt.nz/about/operating-policies-and-procedures/#factorsfc\" rel=\"nofollow\">Factors for Consideration</a>. When we do so, we carefully evaluate clinical and other evidence for the benefits and suitability of a proposal, and to identify and understand the people who will be affected by it.</p>\r\n<p>While our main task is to allocate pharmaceutical funding, we consider the benefits and costs across the whole health system now and with a long-term focus, including the effects for hospitals and primary care, and consider direct costs to patients as well as to all health sector budgets.</p>\r\n<p>Final funding decisions are made by the Pharmac Board or delegated to senior Pharmac staff as required by the Board.</p>\r\n<p>&nbsp;</p>",
    "position": 6,
    "name": "Decision",
    "last": true,
    "events": [
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": "<p><a href=\"https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/decision-on-bulk-fluids-listings-for-dhb-hospitals/\" target=\"_blank\">Decision notification</a></p>",
          "fs": "<p><a href=\"https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/decision-on-bulk-fluids-listings-for-dhb-hospitals/\" target=\"_blank\">Decision notification</a></p>",
          "change": null
        },
        "Formatted_Date": {
          "s": "Mar 2018",
          "fs": "Mar 2018",
          "change": null
        },
        "Event_Description": {
          "s": "The funding application has been approved.",
          "fs": "The funding application has been approved.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000170ZS2AY"
          },
          "Id": "a0POZ00000170ZS2AY",
          "Event_Date__c": "2018-03-09",
          "Event_Description__c": "The funding application has been approved.",
          "Stage__c": "Decision",
          "Links__c": "<p><a href=\"https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/decision-on-bulk-fluids-listings-for-dhb-hospitals/\" target=\"_blank\">Decision notification</a></p>",
          "Formatted_Date__c": "Mar 2018",
          "Status_History__c": "a132P000000ArQnQAK"
        },
        "change": null
      }
    ],
    "dateString": "Mar 2018",
    "collapsed": false,
    "checked": true
  }
]